Supplementary Table S2 from An Early Neoplasia Index (ENI10), Based on Molecular Identity of CD10 Cells and Associated Stemness Biomarkers, is a Predictor of Patient Outcome in Many Cancers — Boris Guyot | RDL Network
Supplementary Table S2 from An Early Neoplasia Index (ENI10), Based on Molecular Identity of CD10 Cells and Associated Stemness Biomarkers, is a Predictor of Patient Outcome in Many Cancers
Dataset en
Authors
BG
Boris Guyot
FC
Flora Clément
YD
Youenn Drouet
Abstract
1 min read
<p>Supplementary Table S2 shows the results of the CD10 IHC staining on a breast cancer tumor micro-array.</p>
Discussion(0)
No comments yet. Be the first to comment.